Iterum Therapeutics Plc Live Stock Price Today, Share Analysis and Chart

Name: Iterum Therapeutics Plc: Is Infosys Ltd. worth buying?
Item: Iterum Therapeutics Plc
Rating: 1.07275
Author: Trendlyne DVM scores

about

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem availabl...

0.70 -0.03 (-4.11%)

76.82% Fall from 52W High

532.8K

XNAS Volume

XNAS 22 Oct, 2025 3:23 PM (EDT)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Neutral

42.9 / 100

No estimates available

Iterum Therapeutics Plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Iterum Therapeutics Plc Live Stock Price Today, Share Analysis and Chart

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem availabl...

76.82% Fall from 52W High

SWOT Analysis

Iterum Therapeutics Plc Live Price Chart